This is the authors' abstract. We don't add key points for this paper.
These initial data demonstrate a high seroprevalence of antibodies to SARS-CoV-2 among HCWs in Kenya. There was significant variation in seroprevalence by region, but not by cadre.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Etyang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: